Vertex Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 04:20PM GMT
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst

Welcome to the first morning of the BofA Healthcare Conference. I'm Geoff Meacham. I'm the senior biopharma analyst here, and we're thrilled to have Vertex Pharmaceuticals in the big room, hopefully no protesting this year. But on behalf of Vertex, we have Charlie Wagner, Executive VP and CFO; and David Altshuler, who is CSO and EVP of Global Research. Guys, welcome.

David M. Altshuler - Vertex Pharmaceuticals Incorporated - Executive VP of Global Research & Chief Scientific Officer

Thank you.

Charles F. Wagner - Vertex Pharmaceuticals Incorporated - Executive VP & CFO

Yes, Geoff, thank you. Thanks for hosting.

Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst

So Charlie, you want to disclose the quarter, just give us a little bit of a high level, and then we'll get into some questions.

Charles F. Wagner - Vertex

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot